Search Results - "PARIKH, HEMANG M."
-
1
Distinct transcriptomic profiles in children prior to the appearance of type 1 diabetes-linked islet autoantibodies and following enterovirus infection
Published in Nature communications (22-11-2023)“…Although the genetic basis and pathogenesis of type 1 diabetes have been studied extensively, how host responses to environmental factors might contribute to…”
Get full text
Journal Article -
2
High-throughput muscle fiber typing from RNA sequencing data
Published in Skeletal muscle (02-07-2022)“…Skeletal muscle fiber type distribution has implications for human health, muscle function, and performance. This knowledge has been gathered using…”
Get full text
Journal Article -
3
Relationship between insulin sensitivity and gene expression in human skeletal muscle
Published in BMC endocrine disorders (27-02-2021)“…Insulin resistance (IR) in skeletal muscle is a key feature of the pre-diabetic state, hypertension, dyslipidemia, cardiovascular diseases and also predicts…”
Get full text
Journal Article -
4
Identification of type 1 diabetes risk phenotypes using an outcome-guided clustering analysis
Published in Diabetologia (01-11-2024)“…Aims/hypothesis Although statistical models for predicting type 1 diabetes risk have been developed, approaches that reveal the heterogeneity of the at-risk…”
Get full text
Journal Article -
5
Oral Insulin Delay of Stage 3 Type 1 Diabetes Revisited in HLA DR4-DQ8 Participants in the TrialNet Oral Insulin Prevention Trial (TN07)
Published in Diabetes care (01-09-2024)“…To explore if oral insulin could delay onset of stage 3 type 1 diabetes (T1D) among patients with stage 1/2 who carry HLA DR4-DQ8 and/or have elevated levels…”
Get full text
Journal Article -
6
155-OR: Genetic Variation and Time to Progression in TN10 (Teplizumab)
Published in Diabetes (New York, N.Y.) (14-06-2024)“…Introduction & Objective: TN10 Anti-CD3 Prevention (TN10) was a randomized phase 2 clinical trial that showed teplizumab delayed progression to type 1 diabetes…”
Get full text
Journal Article -
7
Genetic Associations with C-peptide Levels before Type 1 Diabetes Diagnosis in At-Risk Relatives
Published in The journal of clinical endocrinology and metabolism (20-05-2024)“…We sought to determine whether the type 1 diabetes genetic risk score-2 (T1D-GRS2) and single nucleotide polymorphisms (SNPs) are associated with C-peptide…”
Get full text
Journal Article -
8
1254-P: Genetic Prediction of C-Peptide Trajectory before Type 1 Diabetes Diagnosis in TrialNet
Published in Diabetes (New York, N.Y.) (01-06-2022)“…Modeling the course of C-peptide decline in autoantibody (Ab) positive individuals is important for type 1 diabetes (T1D) prediction and implementation of T1D…”
Get full text
Journal Article -
9
HLA Class II (DR, DQ, DP) Genes Were Separately Associated With the Progression From Seroconversion to Onset of Type 1 Diabetes Among Participants in Two Diabetes Prevention Trials (DPT-1 and TN07)
Published in Diabetes care (01-05-2024)“…To explore associations of HLA class II genes (HLAII) with the progression of islet autoimmunity from asymptomatic to symptomatic type 1 diabetes (T1D)…”
Get full text
Journal Article -
10
Data Mining Framework for Discovering and Clustering Phenotypes of Atypical Diabetes
Published in The journal of clinical endocrinology and metabolism (01-04-2023)“…Abstract Context Some individuals present with forms of diabetes that are “atypical” (AD), which do not conform to typical features of either type 1 diabetes…”
Get full text
Journal Article -
11
Progression to type 1 diabetes in the DPT-1 and TN07 clinical trials is critically associated with specific residues in HLA-DQA1-B1 heterodimers
Published in Diabetologia (01-11-2024)“…Aims/hypothesis The aim of this work was to explore molecular amino acids (AAs) and related structures of HLA-DQA1-DQB1 that underlie its contribution to the…”
Get full text
Journal Article -
12
216-LB: Genetic Influences on Beta-Cell Function before Type 1 Diabetes Diagnosis
Published in Diabetes (New York, N.Y.) (20-06-2023)“…Autoimmune loss of beta-cell function (measured by C-peptide) is the hallmark of type 1 diabetes (T1D) targeted by interventions that aim to prevent T1D or its…”
Get full text
Journal Article -
13
First-appearing islet autoantibodies for type 1 diabetes in young children: maternal life events during pregnancy and the child’s genetic risk
Published in Diabetologia (01-03-2021)“…Aims/hypothesis Psychological stress has long been considered a possible trigger of type 1 diabetes, although prospective studies examining the link between…”
Get full text
Journal Article -
14
243-OR: Integrating Genetic Risk Score and Islet Autoantibody Characteristics in the Predictive Model for Type 1 Diabetes in the TrialNet Study
Published in Diabetes (New York, N.Y.) (01-06-2021)“…Background: Type 1 diabetes (T1D) genetic risk score (GRS) and islet autoantibody (AAb) specificity and titers influence T1D risk; however, these factors…”
Get full text
Journal Article -
15
Race and Ethnicity, Socioeconomic Factors, and Epigenetic Age Acceleration in Survivors of Childhood Cancer
Published in JAMA network open (01-07-2024)“…Current research in epigenetic age acceleration (EAA) is limited to non-Hispanic White individuals. It is imperative to improve inclusivity by considering…”
Get full text
Journal Article -
16
Epigenetic Age in Peripheral Blood Among Children, Adolescent, and Adult Survivors of Childhood Cancer
Published in JAMA network open (03-04-2023)“…Certain cancer therapies are risk factors for epigenetic age acceleration (EAA) among survivors of childhood cancer, and EAA is associated with chronic health…”
Get full text
Journal Article -
17
1462-P: Genetic Risk Score for Type 1 Diabetes across Ethnic Populations via Multitask Learning
Published in Diabetes (New York, N.Y.) (01-06-2024)“…Introduction: Genetic risk scores (GRS) for the prognosis of Stage 3 type 1 diabetes (T1D) are potentially biased due to the predominant race/ethnicity…”
Get full text
Journal Article -
18
68-OR: Influence of the Type 1 Diabetes Genetic Risk Score on Response to Immunotherapies for Type 1 Diabetes Prevention
Published in Diabetes (New York, N.Y.) (01-06-2024)“…Introduction & Objective: Teplizumab has shown efficacy at delaying the onset of type 1 diabetes (T1D) but markers of response to treatment are needed to…”
Get full text
Journal Article -
19
1445-P: Co-occurrence of Islet, Celiac, and Thyroid Autoimmunity in Children Prospectively Followed from Birth in the TEDDY Study
Published in Diabetes (New York, N.Y.) (01-06-2024)“…Islet autoantibodies (IA) that precede type 1 diabetes, tissue transglutaminase autoantibodies (tTGA) preceding celiac disease, and thyroid peroxidase (TPOA)…”
Get full text
Journal Article -
20
1441-P: Low Morning Cortisol in Early Life Associated with Increased Risk of Islet Autoimmunity
Published in Diabetes (New York, N.Y.) (01-06-2024)“…Introduction & Objective: Stress is implicated as a factor in immune reactivity and autoimmune disorders. Adverse experiences and chronic stress may be…”
Get full text
Journal Article